It’s Better to Hope for Prosperity than Become Adversary: AnaptysBio Inc (ANAB) Stock
Leerink Partners raised the price target for the AnaptysBio Inc (NASDAQ:ANAB) stock to “an Outperform”. The rating was released on April 16, 2024, according to finviz. The research report from Wedbush has upgraded the stock from Neutral to Outperform, with a price target set at $34. The stock was initiated by BTIG Research, who disclosed […]
The idea of catching Zomedica Corp (ZOM) Stock might be a good one
Dawson James raised the price target for the Zomedica Corp (AMEX:ZOM) stock to “a Buy”. The rating was released on January 06, 2023, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -6.23% within the last five trades and -18.26% within the last 30 […]
It’s not the right time to quit: Biolife Solutions Inc (BLFS) Stock
Jefferies raised the price target for the Biolife Solutions Inc (NASDAQ:BLFS) stock to “a Buy”. The rating was released on April 04, 2024, according to finviz. The research report from Oppenheimer has upgraded the stock from Perform to Outperform, with a price target set at $28. The stock was initiated by B. Riley Securities, who […]
Top-line Growth is Likely to Be Driven by Great Ajax Corp (AJX) Stock
JMP Securities raised the price target for the Great Ajax Corp (NYSE:AJX) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 12, 2024, according to finviz. The research report from Compass Point has downgraded the stock from Buy to Neutral, with a price target set at $11. In their […]
Does Sable Offshore Corp. (SOC) Stock have plenty of room for growth?
TD Cowen raised the price target for the Sable Offshore Corp. (NYSE:SOC) stock to “an Outperform”. The rating was released on February 26, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -2.70% within the last five trades and 9.89% within the last […]
The Cytek BioSciences Inc (CTKB) Stock expansion path ahead
Stephens raised the price target for the Cytek BioSciences Inc (NASDAQ:CTKB) stock to “an Overweight”. The rating was released on December 14, 2023, according to finviz. The research report from Piper Sandler has resumed the stock to Overweight, with a price target set at $20. The latest trade, Performances and Moving Averages give us the […]
Centrus Energy Corp (LEU) Stock is poised for a successful quarter
B. Riley Securities raised the price target for the Centrus Energy Corp (AMEX:LEU) stock to “a Buy”. The rating was released on October 13, 2023, according to finviz. We previously noted in another research note published on August 08, 2022 by ROTH Capital that upgraded the stock from a Neutral to a Buy with a […]
Facts about ATN International Inc (ATNI) Stock that you might not know
Raymond James raised the price target for the ATN International Inc (NASDAQ:ATNI) stock from “an Outperform” to “a Strong buy”. The rating was released on February 23, 2024, according to finviz. The research report from National Securities has upgraded the stock from Neutral to Buy, with a price target set at $60. The latest trade, […]
There is no better tap than Sigma Lithium Corporation (SGML) Stock
BofA Securities raised the price target for the Sigma Lithium Corporation (NASDAQ:SGML) stock to “a Buy”. The rating was released on December 06, 2023, according to finviz. The stock was initiated by BofA Securities, who disclosed in a research note on January 06, 2022, to Buy and set the price objective to $14. The latest […]
A healthy upside potential exists for Dyne Therapeutics Inc (DYN) Stock
Chardan Capital Markets raised the price target for the Dyne Therapeutics Inc (NASDAQ:DYN) stock to “a Buy”. The rating was released on May 21, 2024, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $36. The stock was upgraded by Raymond James, who […]
